Atlas Trials

A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease

Clinical trial NCT06544694 · COMPLETED

Trial details

NCT number
NCT06544694
Sponsor
Alcon Research
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Dry Eye Disease
Start date
2024-10-08
Primary completion
2025-03-21
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.